TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer
TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer is a paper indexed in ScholarIQ from OpenAlex.
How many citations does TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer have?
TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer has 120 citations in the OpenAlex counts ScholarIQ stores.
When was TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer published?
TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer has 2011 year in the ScholarIQ index.
What is the open-access status of TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer?
TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer has closed oa status in the ScholarIQ index.
What is the DOI of TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer?
The DOI for TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer is on the source record.
What is the PMID of TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer?
The PMID for TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer is on the source record.
What is the OpenAlex record for TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer?
The OpenAlex for TLR3 as a Biomarker for the Therapeutic Efficacy of Double-stranded RNA in Breast Cancer is on the source record.